162 related articles for article (PubMed ID: 21156927)
1. Viral-derived Serp-1 as an adjunctive therapy for percutaneous coronary intervention: another not ready for prime time player?
Leopold JA
Circ Cardiovasc Interv; 2010 Dec; 3(6):528-30. PubMed ID: 21156927
[No Abstract] [Full Text] [Related]
2. A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Tardif JC; L'Allier PL; Grégoire J; Ibrahim R; McFadden G; Kostuk W; Knudtson M; Labinaz M; Waksman R; Pepine CJ; Macaulay C; Guertin MC; Lucas A
Circ Cardiovasc Interv; 2010 Dec; 3(6):543-8. PubMed ID: 21062996
[TBL] [Abstract][Full Text] [Related]
3. Viral serine proteinase inhibitor (SERP-1) effectively decreases the incidence of graft vasculopathy in heterotopic heart allografts.
Hausen B; Boeke K; Berry GJ; Morris RE
Transplantation; 2001 Aug; 72(3):364-8. PubMed ID: 11502962
[TBL] [Abstract][Full Text] [Related]
4. Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty.
Lucas A; Liu L; Macen J; Nash P; Dai E; Stewart M; Graham K; Etches W; Boshkov L; Nation PN; Humen D; Hobman ML; McFadden G
Circulation; 1996 Dec; 94(11):2890-900. PubMed ID: 8941118
[TBL] [Abstract][Full Text] [Related]
5. The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics.
Lucas A; Liu L; Dai E; Bot I; Viswanathan K; Munuswamy-Ramunujam G; Davids JA; Bartee MY; Richardson J; Christov A; Wang H; Macaulay C; Poznansky M; Zhong R; Miller L; Biessen E; Richardson M; Sullivan C; Moyer R; Hatton M; Lomas DA; McFadden G
Adv Exp Med Biol; 2009; 666():132-56. PubMed ID: 20054981
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of antigen induced arthritis in rabbits treated with a secreted viral serine proteinase inhibitor.
Maksymowych WP; Nation N; Nash P; Macen J; Lucas A; McFadden G; Russell AS
J Rheumatol; 1996 May; 23(5):878-82. PubMed ID: 8724302
[TBL] [Abstract][Full Text] [Related]
7. Can a viral serine proteinase inhibitor prevent postangioplasty restenosis?
Haber E
Circulation; 1996 Dec; 94(11):2694-5. PubMed ID: 8941089
[No Abstract] [Full Text] [Related]
8. Serpins for diagnosis and therapy in cancer.
Zheng D; Chen H; Davids J; Bryant M; Lucas A
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):123-32. PubMed ID: 23988000
[TBL] [Abstract][Full Text] [Related]
9. Radial approach for primary percutaneous coronary intervention: ready for prime time?
Bertrand OF; Patel T
J Am Coll Cardiol; 2012 Dec; 60(24):2500-3. PubMed ID: 23237562
[No Abstract] [Full Text] [Related]
10. Serpins as therapeutics--a potential biologic source for unique protein-based therapeutics.
Lucas A
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):89. PubMed ID: 23987996
[No Abstract] [Full Text] [Related]
11. Anti-apoptotic serpins as therapeutics in cardiovascular diseases.
Kuiper J; Quax PH; Bot I
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):111-22. PubMed ID: 23987999
[TBL] [Abstract][Full Text] [Related]
12. [Percutaneous coronary intervention through an axillo-bifemoral bypass].
Lozano I; Rondán J; Martín M; Vega F
Rev Esp Cardiol; 2011 Nov; 64(11):1073-4. PubMed ID: 21715079
[No Abstract] [Full Text] [Related]
13. The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation.
Chen H; Davids JA; Zheng D; Bryant M; Bot I; van Berckel TJ; Biessen E; Pepine C; Ryman K; Progulski-Fox A; Kesavalu L; Moyer R; McFadden G; Lucas A
Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):99-110. PubMed ID: 23987998
[TBL] [Abstract][Full Text] [Related]
14. Serpins, the vasculature, and viral therapeutics.
Richardson J; Viswanathan K; Lucas A
Front Biosci; 2006 Jan; 11():1042-56. PubMed ID: 16146796
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology and pharmacokinetics of LEX 032, a bioengineered serpin: the first of a potential new class of drugs.
Sands H; Hook JB
Drug Metab Rev; 1997; 29(1-2):309-28. PubMed ID: 9187523
[No Abstract] [Full Text] [Related]
16. Suppression of collagen-induced arthritis with a serine proteinase inhibitor (serpin) derived from myxoma virus.
Brahn E; Lee S; Lucas A; McFadden G; Macaulay C
Clin Immunol; 2014 Aug; 153(2):254-63. PubMed ID: 24845791
[TBL] [Abstract][Full Text] [Related]
17. The role of angioplasty in octogenarian patients with Acute Coronary Syndrome.
Potluri R; Reynolds J; Carter P; Baig M; Aziz A; Potluri S; Ali N; Uppal H; Chandran S
Int J Cardiol; 2016 Jan; 202():430-2. PubMed ID: 26433166
[No Abstract] [Full Text] [Related]
18. [The MATRIX study].
Tarantino F; Pavei A; Trani C
G Ital Cardiol (Rome); 2015 Oct; 16(10):519-24. PubMed ID: 26444208
[No Abstract] [Full Text] [Related]
19. [Primary percutaneous coronary angioplasty in patients with acute coronary syndrome and concomitant cancer].
Goloshchapov-Aksenov RS; Lebedev AV; Mirzonov VA
Vestn Rentgenol Radiol; 2012; (1):17-20. PubMed ID: 22679809
[TBL] [Abstract][Full Text] [Related]
20. Viral serine protease inhibitors as anti-atherosclerotic therapy.
Bot I; van Berkel TJ; Biessen EA
Curr Opin Investig Drugs; 2007 Sep; 8(9):729-35. PubMed ID: 17729184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
